NM_000053.4:c.4021+50G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000053.4(ATP7B):​c.4021+50G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.577 in 1,565,232 control chromosomes in the GnomAD database, including 262,397 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 24230 hom., cov: 30)
Exomes 𝑓: 0.58 ( 238167 hom. )

Consequence

ATP7B
NM_000053.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.499

Publications

13 publications found
Variant links:
Genes affected
ATP7B (HGNC:870): (ATPase copper transporting beta) This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019]
ATP7B Gene-Disease associations (from GenCC):
  • Wilson disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 13-51937226-C-G is Benign according to our data. Variant chr13-51937226-C-G is described in ClinVar as Benign. ClinVar VariationId is 254770.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.587 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP7BNM_000053.4 linkc.4021+50G>C intron_variant Intron 19 of 20 ENST00000242839.10 NP_000044.2 P35670-1B7ZLR4A0A024RDX3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP7BENST00000242839.10 linkc.4021+50G>C intron_variant Intron 19 of 20 1 NM_000053.4 ENSP00000242839.5 P35670-1

Frequencies

GnomAD3 genomes
AF:
0.564
AC:
85469
AN:
151626
Hom.:
24220
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.530
Gnomad AMI
AF:
0.429
Gnomad AMR
AF:
0.597
Gnomad ASJ
AF:
0.568
Gnomad EAS
AF:
0.406
Gnomad SAS
AF:
0.523
Gnomad FIN
AF:
0.602
Gnomad MID
AF:
0.651
Gnomad NFE
AF:
0.586
Gnomad OTH
AF:
0.584
GnomAD2 exomes
AF:
0.566
AC:
140122
AN:
247424
AF XY:
0.565
show subpopulations
Gnomad AFR exome
AF:
0.522
Gnomad AMR exome
AF:
0.634
Gnomad ASJ exome
AF:
0.574
Gnomad EAS exome
AF:
0.396
Gnomad FIN exome
AF:
0.610
Gnomad NFE exome
AF:
0.581
Gnomad OTH exome
AF:
0.583
GnomAD4 exome
AF:
0.578
AC:
817418
AN:
1413492
Hom.:
238167
Cov.:
28
AF XY:
0.577
AC XY:
407071
AN XY:
705734
show subpopulations
African (AFR)
AF:
0.533
AC:
17276
AN:
32422
American (AMR)
AF:
0.633
AC:
28185
AN:
44532
Ashkenazi Jewish (ASJ)
AF:
0.573
AC:
14811
AN:
25834
East Asian (EAS)
AF:
0.402
AC:
15826
AN:
39406
South Asian (SAS)
AF:
0.521
AC:
44332
AN:
85140
European-Finnish (FIN)
AF:
0.606
AC:
32344
AN:
53336
Middle Eastern (MID)
AF:
0.631
AC:
3584
AN:
5682
European-Non Finnish (NFE)
AF:
0.587
AC:
627251
AN:
1068322
Other (OTH)
AF:
0.575
AC:
33809
AN:
58818
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
19319
38637
57956
77274
96593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16884
33768
50652
67536
84420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.564
AC:
85523
AN:
151740
Hom.:
24230
Cov.:
30
AF XY:
0.563
AC XY:
41754
AN XY:
74102
show subpopulations
African (AFR)
AF:
0.530
AC:
21898
AN:
41350
American (AMR)
AF:
0.597
AC:
9119
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.568
AC:
1967
AN:
3464
East Asian (EAS)
AF:
0.407
AC:
2092
AN:
5142
South Asian (SAS)
AF:
0.523
AC:
2509
AN:
4796
European-Finnish (FIN)
AF:
0.602
AC:
6306
AN:
10474
Middle Eastern (MID)
AF:
0.648
AC:
188
AN:
290
European-Non Finnish (NFE)
AF:
0.586
AC:
39816
AN:
67924
Other (OTH)
AF:
0.586
AC:
1238
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1900
3800
5701
7601
9501
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.576
Hom.:
4665
Bravo
AF:
0.563
Asia WGS
AF:
0.526
AC:
1824
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 10, 2016
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Wilson disease Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.82
DANN
Benign
0.49
PhyloP100
-0.50
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9535795; hg19: chr13-52511362; COSMIC: COSV54442967; COSMIC: COSV54442967; API